Health-care companies fell as traders rotated into cyclical sectors.
Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, and named Kellanova Chief Financial Officer Amit Banati as its financial chief.
Shares of troubled Covid-19 vaccine developer Novavax rose sharply after it logged a significant profit, boosted by payments related to the termination of two purchase contracts.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
May 08, 2025 18:27 ET (22:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.